{"name":"Forendo Pharma Ltd","slug":"forendo-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOdF8yTXJlNGFhOHdaMGItM3pkRVVxSDJ1XzlUcHFEamVvSXI0dlZHTjB1ZXQwZHM1Y21sVDlJTEt2a3NEQUo5RV95TTctYUtXcDlVNDFabDVMa3F3UFRwU0RRRFl2cTdyc1Z4S3VSeFJyY2pMZWQ1akxaU3dBeS1ETUJuQmlrS2hRSVRldFRLOUdaUUY0dlE3R2I3Uk9HczZEZDFtZXJhVQ?oc=5","date":"2025-11-18","type":"regulatory","source":"BioWorld News","summary":"Henlius, Organon win US FDA approval of first Perjeta biosimilar - BioWorld News","headline":"Henlius, Organon win US FDA approval of first Perjeta biosimilar","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPR1RrMzdORmZadENVaC1XdTlsS0hsNmgwS2tHWUd5ZUgzVUhqWWRISmVSRHBpaDhnNEFRNHVaVU9ZX1J6cFlReGYwX01oSE13a0Z2bXhiengxUXZrd3phZXdfcUVZZjZGQ3BXbnp5Qk03bEg5UGs5NVE4T3MtRlFaRV9pV1RXMTJBNlhkcUFlRS1wR1p5enlnOTdOTQ?oc=5","date":"2025-07-03","type":"trial","source":"Clinical Trials Arena","summary":"Organon discontinues endometriosis drug after Phase II flunk - Clinical Trials Arena","headline":"Organon discontinues endometriosis drug after Phase II flunk","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOeC1sZHJaaDVsVk5ydWVnS3c0aUdZVms3UkNmX3ZOckZIX0pGWmdPX3F6R1hTOWxpYlo4QkR5bThxNXBEay0yUF9xVWtsazRDdXJZQkFRcDhsdzlVWlZvbFNyc0RiV3RkMlcxS1BBM3dsalA1SERoUzJVaExyV0RqWTZreC1fel9iMmtVSV9GTWw4VEh5VGZ2UFVQNXQ3SEFILThCdkdrS3ljTGgxMUt2cXh3?oc=5","date":"2025-07-02","type":"pipeline","source":"BioSpace","summary":"Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain - BioSpace","headline":"Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTHFTYmU2eDVKbDBjM2hucGdkTnJic1ZHWkptUEZCaHJ1R0FobkRTSXl5QnJwT1ZVck50NTJjRWhuMkJfTDZtNWZmaXVsMl84amwxRGVPekRZZGJqVmptNjdOdER4WDlpZkZjakNwMVNpS2RzUk8zLVRKTDcyQXV2ZnJLczhrQVRpMzRnQlpiOE5heEw1Vno4ZkR2NA?oc=5","date":"2025-07-02","type":"trial","source":"MedCity News","summary":"Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test - MedCity News","headline":"Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPRXdkOVNHZmdFTHBndngwUnFDZTZCM1NPZ3BvV2lBSlJCMWFZM1JDQ2JvbS1ONmlWZV9QX0J2MzRqNXUydkw4WGFUWFYxbUVqWU1SM1R2aXVRLUF0UjE1bm5iMlFJTEdYMmhuM3FrOVRWdDRTcVdfQllwVUlsU2hLeVhsM0hoeFMtZkVzSFFvUklIYmdBQVdhanZfN2Vyd0c0S0tDS0VobTNlN3pJUGxhRg?oc=5","date":"2024-12-09","type":"pipeline","source":"BioPharma Dive","summary":"Endometriosis drug research, long underfunded, confronts familiar problems in women’s health - BioPharma Dive","headline":"Endometriosis drug research, long underfunded, confronts familiar problems in women’s health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPLU1EZTNwb0dzaXVLb2hTckFZY0NyNlVXTzVCOE5lRlZnSjd5MWt5TnVJemZOeUpVLXFYWmdPTHhocVR2TFlWRHpabXRIbHJ1N0FBY0RqZ1FXblNxYzZwS0t3UEUtVEdkSDE3NjAzYV9KVTVySllpZU1JMHBlRi0xbVFFRQ?oc=5","date":"2024-09-11","type":"pipeline","source":"Pharmaceutical Executive","summary":"Making the Leap from Pharmaceuticals to Private Equity, Venture Capital - Pharmaceutical Executive","headline":"Making the Leap from Pharmaceuticals to Private Equity, Venture Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPMm1WVDFWc0YwVmFiSVZZd0RkQzVOSzBxd2lOSjU3MjNIcDRwcERCX1NseXBvN3lsUWVkN3VvSXRGU2xTem9KVll0X0o4MUFhWFZkX0x1QVJZMjFoT25PMXh6c3pnREtzN05fdWJ6QlhkM2tnMHRmMk5CMjJReFhNNWhVTmVueGZUXzc0eE9vMnBCR282aEhJSzBDZFo?oc=5","date":"2024-01-19","type":"pipeline","source":"Endocrine Society","summary":"Continuing Education - Endocrine Society","headline":"Continuing Education","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1qaDJ1c2RGamZOWVpESzhIbllwaXU3ejBZRFMydWMxemFvTndqRXhYZ1JxUGdKSWc3TXhMRUxRRm1RUmNtODRHWTZwb0lFbFAxVmVpOGZPVV96bVVKdXduNlcwQUQybFE3UW01X2FiZUtlLUlhbjYyZnN3?oc=5","date":"2021-11-12","type":"deal","source":"Pharmaceutical Technology","summary":"Organon to acquire drug development company Forendo Pharma - Pharmaceutical Technology","headline":"Organon to acquire drug development company Forendo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPX1BwcjV0dHlyQXlNc0NkUkUxV0hJU0VEVU1xdnBELVhBNUZ6RUZSN1ZZa0lsUWVVNmprSVVkdmh3ODZrN0Roc0VjRW03Rm1RQ1BSN1dZR1ZFRFpLQ0VuUkY3U0JSdGlmTzlIRHJMU0pfQ2dMX3g3V0NfZmtRZ0gwdWJyMWdoYWlfVDY4a0gyY2RqZko3?oc=5","date":"2021-11-11","type":"deal","source":"businesswire.com","summary":"Organon to Acquire Forendo Pharma - businesswire.com","headline":"Organon to Acquire Forendo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbi1VVEU5bzZqYkhKbE44bkRkNlF2MHVXR3JMcVdVZVo3X2ZHck9QSWxXUWRlS3luRUhPa2ppcmQzb2l0YzdHOFZ3QXg3SE9QSFRhUmtOYjZKdDBjTmtxUlhrZWM1M0Z5SmNUZlhoYlRqOVQ1VTFsNTFZck9hVmpXWVNIZzVwU2hUeVpiOEZTNTlnV3ZrWlF1YWg4a0hnQnM3WHNWOGdYRU02ZkZmc0d5czVrUy0yWUFz?oc=5","date":"2021-11-11","type":"deal","source":"MedCity News","summary":"Organon makes another women’s health move with deal for endometriosis-focused Forendo - MedCity News","headline":"Organon makes another women’s health move with deal for endometriosis-focused Forendo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNSXFfMHIyd0NUWUZ5YWtrWHh6ckVULTlxanRFS0ZYeEY3Q2xibGUtZGxMTzFQcmhINThKVWtzWE9MbUJjbEZMeWo2c19SZXE2QXN6c3ZWUUIwRTJBMmxfcEpNdTZfU1FKdVA5ZFBYRzM0Mnd0ZkZjTzBoclhZeWdZN3lBUkhXSXBHcFkxU2x2bUNOVkd0RzJ6TDJfdHdiNTlKbUxSNlBWcUhxT2lYVzRSeA?oc=5","date":"2021-03-03","type":"trial","source":"European Pharmaceutical Review","summary":"FOR-6219 shows promise in Phase I endometriosis trial - European Pharmaceutical Review","headline":"FOR-6219 shows promise in Phase I endometriosis trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOTkh1NUdhRUNncDNQZ2xoblFScVJkSlR4MXlpVW5zOHBlY045elVrbHRKMXhIYWQxVkNJbk4tTk9ZZGlYMVl2OXI3bC1EeEtTTVVQZ090UG03ZmJwM3ZZd2xHVmhHM1hFQUF6RXdxQUZBa2JIQXVPYnpBMFVlTWE3TmhGVVJBQ0NDVDdBYmtEMVRabFU0ajVoYXdCamxOUG02VGNCQnNaUU10Si1ZbFpnNWtITzFsMmVhN2ltXzA0ODY3SG5RN0U3OW1Takk3NFVqV0x3S0RJU3dhVFlrY1haUVJ2eTRtVElnRnluMDNzMFctNGlOVHE0dTZQUXN1MU0?oc=5","date":"2020-08-25","type":"pipeline","source":"European Medical Journal","summary":"Local Steroid Metabolism in Eutopic Endometrium and Corresponding Endometriotic Lesions: Intra-Patient Variability - European Medical Journal","headline":"Local Steroid Metabolism in Eutopic Endometrium and Corresponding Endometriotic Lesions: Intra-Patient Variability","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}